• GreenLight Biosciences Science Day updates investors on progress across human, plant and animal health

    1 month ago - By Green Light Biosciences

    7 agricultural products in development with an addressable market of $6bn that we plan to launch by 2026.
    Control of fungal pathogens using double-stranded RNA has been demonstrated in field testing for the first time. This addresses the number one cause of food rotting.
    Varroa mite: Higher brood and health scores compared to chemical controls.
    Promising antibody response and cell-mediated immunity for GreenLight Covid-19 vaccine candidates in mice. Data indicates feasibility of initiating clinical trial in Africa for COVID-19 vaccine candidate.
    Gene therapy: Bill & Melinda Gates...
    Read more ...